Blog 2 — AAX BIOTECH

Media

Get the latest news from AAX and in the press here.

From AAX

Featured

AAX Biotech to present a poster at T-Cell Engager Therapeutics Summit Europe in London

Nov 24, 2025

AAX Biotech to present a poster at T-Cell Engager Therapeutics Summit Europe in London

Nov 24, 2025

Nov 24, 2025

AAX Biotech and ToxoTech Join Forces to Advance Next-Generation Biotherapeutics for Neurological Disorders

Nov 6, 2025

AAX Biotech and ToxoTech Join Forces to Advance Next-Generation Biotherapeutics for Neurological Disorders

Nov 6, 2025

Nov 6, 2025

AAX Biotech Featured in Ventures Accelerated Interview at NLSDays 2025

Oct 30, 2025

AAX Biotech Featured in Ventures Accelerated Interview at NLSDays 2025

Oct 30, 2025

Oct 30, 2025

AAX Biotech to present poster at PEGS Europe 2025

Oct 28, 2025

AAX Biotech to present poster at PEGS Europe 2025

Oct 28, 2025

Oct 28, 2025

AAX Biotech Announces Collaboration with Daiichi Sankyo to Evaluate Opti-mAb® Technology in Next-Generation Antibody Therapeutics

Oct 22, 2025

AAX Biotech Announces Collaboration with Daiichi Sankyo to Evaluate Opti-mAb® Technology in Next-Generation Antibody Therapeutics

Oct 22, 2025

Oct 22, 2025

AAX Biotech to attend BIO-Europe 2025

Oct 16, 2025

AAX Biotech to attend BIO-Europe 2025

Oct 16, 2025

Oct 16, 2025

AAX CSO Daniel X. Johansson featured in INNOVATE™ Stockholm

Sep 29, 2025

AAX CSO Daniel X. Johansson featured in INNOVATE™ Stockholm

Sep 29, 2025

Sep 29, 2025

AAX in the news